Features of IgM-Secreting Myeloma Patients
Patients . | Age (yr) . | Serum IgM (g/L) . | Light Chain Type . | % BM Plasma Cells . | Osteolytic Lesions . |
---|---|---|---|---|---|
CLE | 77 | 21 | κ | 50 | + |
DEZ | 56 | 60 | κ | 15 | − |
JON | 76 | 35 | λ | 15 | + |
MOR* | 85 | 66 | κ | 32 | + (H Ca)† |
BEC | 70 | 50 | λ | 12 | − |
BAR‡ | 57 | 45 | κ | 17 | − |
Patients . | Age (yr) . | Serum IgM (g/L) . | Light Chain Type . | % BM Plasma Cells . | Osteolytic Lesions . |
---|---|---|---|---|---|
CLE | 77 | 21 | κ | 50 | + |
DEZ | 56 | 60 | κ | 15 | − |
JON | 76 | 35 | λ | 15 | + |
MOR* | 85 | 66 | κ | 32 | + (H Ca)† |
BEC | 70 | 50 | λ | 12 | − |
BAR‡ | 57 | 45 | κ | 17 | − |